Correction to "Trametinib Overcomes KRAS-G12V-Induced Osimertinib Resistance in a Leptomeningeal Carcinomatosis Model of EGFR-Mutant Lung Cancer". . Cancer Sci 2025 Nov 24. doi: 10.1111/cas.70278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to "Trametinib Overcomes KRAS-G12V-Induced Osimertinib Resistance in a Leptomeningeal Carcinomatosis Model of EGFR-Mutant Lung Cancer". Cancer Sci 2025 Nov 24. doi: 10.1111/cas.70278.
PMID: 41287226